Long-term Safety with the SYNERGY Stent System

SYNERGY EVOLVE Clinical Data Infographic SYNERGY EVOLVE Clinical Data Infographic

* In a landmark analysis at 24 hours.
Current guidelines recommend that dual anti-platelet therapy (DAPT) with aspirin and an ADP receptor antagonist be continued for a minimum of 12-months following drug-eluting stent (DES) percutaneous coronary intervention (PCI).
1 Presented by D. Kereiakes, MD at ACC 2016.
2 Meredith, I, AM, MBBS, PhD. PCR 2016. Only the “full dose” SYNERGY Stent results are shown.
3 James, S. Adapted from presentation at TCT 2015.